I. Horowitz

发表

Epidemiologic and viral factors associated with cervical neoplasia in HPV‐16‐positive women

Daisy R. Lee, G. Birdsong, M. Husain, 2005, International journal of cancer.

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.

R. Ozols, J. Walczak, R. Alvarez, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidemiology of adenocarcinoma of the cervix

L. Jacobson, I. Horowitz, J. Currie, 1989, Gynecologic oncology.

Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background.

A. Klein-Szanto, Elizabeth R. Smith, Xiang-Xi Xu, 2006, The American journal of pathology.

Margins for cervical and vulvar cancer

N. Khanna, I. Horowitz, L. Rauh, 2016, Journal of surgical oncology.

Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.

P. Johnstone, P. Rossi, A. Jani, 2007, International journal of radiation oncology, biology, physics.

Use of Unsolicited Patient Observations to Identify Surgeons With Increased Risk for Postoperative Complications

Thomas F. Catron, Oscar D. Guillamondegui, D. Spain, 2017, JAMA surgery.

Female Genital System

I. Horowitz, 2010 .

The role of chemotherapy and radiotherapy in the treatment of endometrial carcinoma

H. Shingleton, I. Horowitz, 1997 .

Cervical carcinoma: contemporary management.

I. Horowitz, J. Basil, 2001, Obstetrics and gynecology clinics of North America.

Multiple Anticancer Activities of EF24, a Novel Curcumin Analog, on Human Ovarian Carcinoma Cells

Robert N. Taylor, Ruo-Pan Huang, D. Liotta, 2010, Reproductive Sciences.

Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.

P. Rose, M. Markman, I. Horowitz, 2007, Gynecologic oncology.

Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.

S. Waggoner, P. Rose, I. Horowitz, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens.

P. Rose, I. Horowitz, W. Mcguire, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased glycodelin levels in gynecological malignancies

S. Parthasarathy, I. Horowitz, I. Horowitz, 2001, International Journal of Gynecologic Cancer.

Cervical cancer survival in a high risk urban population

W. Reeves, S. Vernon, E. Unger, 1995 .

Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital.

W. Reeves, E. Unger, R. Nisenbaum, 1998, Journal of the National Medical Association.

Angiogenic role for glycodelin in tumorigenesis

S. Parthasarathy, J. Rock, I. Horowitz, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?

H. Khoury, A. Winkler, M. Arellano, 2012, Chest.

Age-Group Differences in Human Papillomavirus Types and Cofactors for Cervical Intraepithelial Neoplasia 3 among Women Referred to Colposcopy

Daisy R. Lee, J. Gargano, G. Birdsong, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Evaluation of RNA Markers for Early Detection of Cervical Neoplasia in Exfoliated Cervical Cells

Daisy R. Lee, G. Longton, G. Birdsong, 2007, Cancer Epidemiology Biomarkers & Prevention.

Effect of RU‐486 and Related Compounds on the Proliferation of Cultured Macrophages

S. Parthasarathy, I. Horowitz, A. Murphy, 1995, American journal of reproductive immunology.

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

P. Fracasso, S. Waggoner, G. Sutton, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphoepithelioma-Like Carcinoma of the Uterine Cervix

I. Horowitz, E. Skinner, B. Majmudar, 2000, Southern medical journal.

Serum levels of macrophage colony-stimulating factor-1 in cervical human papillomavirus infection and intraepithelial neoplasia.

R. Tekmal, I. Horowitz, R. Adam, 1999, American journal of obstetrics and gynecology.

A statement on abortion by 100 professors of obstetrics: 40 years later.

Grow, L. Giudice, I. Merkatz, 2013, Contraception.

A statement on abortion by 100 professors of obstetrics: 40 years later.

Grow, L. Giudice, I. Merkatz, 2013, American journal of obstetrics and gynecology.

requires production of reactive oxygen species Angiotensin II stimulation of VEGF mRNA translation

Robert N. Taylor, Ruo-Pan Huang, H. Abboud, 2011 .

Acute hyperglycemia following intraperitoneal irrigation with 10% dextrose in a patient with pseudomyxoma peritonei.

B. Thomas, I. Horowitz, W. J. Roy, 1997, Gynecologic oncology.

Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy

N. Khanna, I. Horowitz, K. Hanley, 2020, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Epidemiology of adenocarcinoma of the cervix

I. Horowitz, J. Currie, LP Jacobson, 1988, Gynecologic oncology.

HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners.

W. Reeves, P. Ghys, S. Vernon, 1999, Sexually transmitted infections.

Granular cell tumors of the vulva.

I. Horowitz, P. Copas, B. Majmudar, 1995, American journal of obstetrics and gynecology.

Candidal Retinitis in a Gynecologic Patient

Jennifer I. Lim, I. Horowitz, C. Spann, 1995, Infectious diseases in obstetrics and gynecology.

Basal cell carcinoma due to radiotherapy for carcinoma of the cervix.

I. Horowitz, C. Spann, P. Copas, 1995, Southern medical journal.

Phase II Trial of Trastuzumab in Women with Advanced or Recurrent , HER 2-Positive Endometrial Carcinoma : a Gynecologic Oncology Group Study

J. Berek, J. Fiorica, G. Fleming, 2010 .

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.

J. Berek, J. Fiorica, G. Fleming, 2010, Gynecologic oncology.

Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas

N. Khanna, C. Cohen, I. Horowitz, 2016, Applied immunohistochemistry & molecular morphology : AIMM.

Enhanced Protein Profiling Arrays with ELISA-Based Amplification for High-Throughput Molecular Changes of Tumor Patients’ Plasma

Ruo-Pan Huang, Ruo-Pan Huang, S. Parthasarathy, 2004, Clinical Cancer Research.

Molecular Profiling of Circulating Cytokine Levels in Human Ovarian Cancer Patients.

Ruo-Pan Huang, S. Parthasarathy, I. Horowitz, 2004, Cancer genomics & proteomics.

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group.

K. Darcy, M. Bookman, I. Horowitz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis for steroid production of a Sertoli-Leydig cell tumor.

J. Rock, D. Symonds, I. Horowitz, 1994, Gynecologic Oncology.

Selective vascular embolization in benign gynecologic conditions.

I. Horowitz, F. Osterman, J. Currie, 1994, The Journal of reproductive medicine.

Uterine arteriovenous malformation necessitating hysterectomy with bilateral salpingo-oophorectomy in a young pregnant patient.

I. Horowitz, B. Majmudar, N. Ghanee, 1998, Archives of pathology & laboratory medicine.

Endometrial adenocarcinoma following endometrial ablation for postmenopausal bleeding.

I. Horowitz, W. Mcguire, C. Spann, 1995, Gynecologic oncology.

Improving the cost‐effective evaluation and management of atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesions

I. Horowitz, 1998, Cancer.

Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners.

W. Reeves, P. Ghys, S. Vernon, 1999, Sexually transmitted infections.

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

D. Alberts, P. Brown, A. Berchuck, 2017, Clinical Cancer Research.

Bilateral tubo-ovarian abscesses four years after total abdominal hysterectomy.

S. Bhoola, I. Horowitz, L. Méndez, 1998, Infectious diseases in obstetrics and gynecology.

Successful Treatment of an Adolescent With Locally Advanced Cervicovaginal Clear Cell Adenocarcinoma Using Definitive Chemotherapy and Radiotherapy

M. Durham, H. Katzenstein, N. Esiashvili, 2012, Journal of pediatric hematology/oncology.

Malignant Disease

I. Horowitz, 1941, Current opinion in obstetrics & gynecology.

Squamous cell carcinoma of the cervix metastatic to a drain site.

I. Horowitz, C. Spann, P. Copas, 1995, Gynecologic oncology.

Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status

A. Berchuck, M. Greene, S. Buys, 2011, Cancer Prevention Research.

The promise of cytokine antibody arrays in the drug discovery process

Ruo-Pan Huang, Xuan Cao, Ruo-Pan Huang, 2005, Expert opinion on therapeutic targets.

What's new in gynecology and obstetrics.

I. Horowitz, 2003, Journal of the American College of Surgeons.

Embryonal rhabdomyosarcoma of the uterus in a postmenopausal woman. Case report and review of the literature.

I. Horowitz, S. Logani, K. Moller, 2006, Gynecologic oncology.

Basal cell carcinoma of the vulva. A report of four cases.

I. Horowitz, C. Spann, P. Copas, 1996, The Journal of reproductive medicine.

Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer.

W. Reeves, S. Vernon, E. Unger, 1995, The Journal of infectious diseases.

Lymphadenectomy for patients with cervical cancer: Is it of value?

P. Johnstone, P. Rossi, A. Jani, 2009, Journal of surgical oncology.

Controversies in the management of advanced ovarian cancer.

N. Khanna, I. Horowitz, 2011, Oncology.

Dermatomyositis and lichen myxedematosus. A clinical, histopathological and electron microscopic study.

B. Johnson, I. Horowitz, D. Cooper, 1973, Dermatologica.

Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer.

Jun Xie, S. Mohammed, I. Horowitz, 2009, Prostaglandins, leukotrienes, and essential fatty acids.

A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: a Gynecologic Oncology Group study.

G. Fleming, I. Horowitz, M. Chen, 2006, Gynecologic oncology.

The Role of Uterosacral Ligament Resection in Conservative Operations for Recurrent Endometriosis

J. Rock, I. Horowitz, M. Damario, 1994 .

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

D. Alberts, P. Brown, A. Berchuck, 2017, Clinical Cancer Research.

Multiple Anticancer Activities of EF24, a Novel Curcumin Analog, on Human Ovarian Carcinoma Cells

Robert N. Taylor, Ruo-Pan Huang, D. Liotta, 2010, Reproductive Sciences.